CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Grant or award General Counsel acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy President and CEO bought 16,000 shares at $6.32 ($101,120)
- 4 Open-market buy President and CEO bought 16,000 shares at $6.32 ($101,120)
- 4 Open-market sale Director sold 2,500 shares at $14.70 ($36,749)
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at $15.02 ($225,350)
- 4 Open-market sale Director sold 2,000 shares at $15.24 ($30,480)
- 4 Open-market sale Director sold 5,000 shares at $13.90 ($69,501)
- 4 Open-market sale CFO sold 40,000 shares at $14.02 ($560,860)
- 4 Open-market sale Director sold 22,000 shares at $14.32 ($315,005)
- 4 Open-market sale CFO sold 16,000 shares at $18.77 ($300,290)
- 4 Open-market sale Director sold 3,148 shares at $15.98 ($50,296)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 125,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 210,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO acquired 70,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 17 of 25 · 497 filings